Dr. Vandewalker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 W Nifong Blvd
Suite 2b
Columbia, MO 65203Phone+1 573-446-7000Fax+1 573-445-1000
Summary
- I am a BC allergist in specialty practice for almost 40 years in mid-Missouri. In addition to part-time employment with Family Allergy and Asthma of Louisville, I serve as Medical Director for Clinical Research of the Ozarks. We have conducted over 500 clinical trials of new allergy and asthma drugs during three decades. I teach outpatient allergy/asthma management skills to medical students and residents who rotate through my office. I consult and speak for several pharma companies and have been privileged to serve my specialty in leadership at state and national levels. I plan to fund a research grant in Allergy/Immunology at St Louis U. School of Medicine, my alma mater.
Education & Training
- Fitzsimons Army Medical CenterFellowship, Allergy and Immunology, 1983 - 1985
- Fitzsimons Army Medical CenterResidency, Pediatrics, 1978 - 1981
- Saint Louis University School of MedicineClass of 1978
Certifications & Licensure
- MO State Medical License 1985 - 2026
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow, American College of Allergy, Asthma, and Immunology ACAAI, 1986
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Publications & Presentations
PubMed
- 2 citationsAn Update on Treatment Options for Children and Adults With Asthma.Alan Kaplan, Mark L Vandewalker
The Journal of Family Practice. 2018-10-01 - 44 citationsSafety and efficacy of tiotropium in children aged 1–5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trialElianne J.L.E. Vrijlandt, Georges El Azzi, Mark Vandewalker, Ned Rupp, Thomas Harper
The Lancet. Respiratory Medicine. 2018-02-01 - 55 citationsTiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 PhenotypeThomas B. Casale, Eric D. Bateman, Mark Vandewalker, J. Christian Virchow, Hendrik Schmidt
The Journal of Allergy and Clinical Immunology. in Practice. 2017-11-21
Press Mentions
- New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma – Regardless of Allergy Subtype1,2,3March 8th, 2016
Research History
- Medical Director/Principal InvestigatorI have conducted over 500 FDA-reviewed clinical trials involving allergic rhinitis, asthma, allergic conjunctivitis, chronic urticaria, COPD, and pharmacokinetic studies.1990 - Present
Professional Memberships
- Fellow
- Fellow
- Hal Nelson Society of Military AllergistsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: